A discussion between our CEO + University of Oxford’s Sarah Gilbert | Ferrovial
August 07, 2020
Our CEO, Ignacio Madridejos, sat down with Sarah Gilbert, one of the researchers who is leading the development of the COVID-19 vaccine at the University of Oxford. They discussed the vaccine in-depth and how our donation of €500,000 is helping them in their research. This donation was part of our #FerrovialTogetherCOVID19 fund.
- Top 10 construction industry trends for 2023Built Environment
- Skanska London office awarded SmartScore PlatinumConstruction Projects
- CLC calls for easier access to overseas construction workersConstruction Projects
- Bechtel selected to build 2 new motorways in North MacedoniaConstruction Projects